IV-push

As the Court held: Wyeth did not need FDA approval to tell the medical community that Phenergran was too dangerous to be administered via IV-push.

The Court Made the Right Decision in the Wyeth Case 2009

Contrary to suggestions made in the article, the essential facts of this case are very clear and weren't challenged: There is no evidence, argument, or even suggestion that Wyeth concealed or failed to provide the Food and Drug Administration with any relevant information about Phenergan, and the FDA was fully aware of the risks posed by IV-push administration of the drug (as was the treating physician) when making its labeling decision.

Tragic Injury Wasn't the Drug's Fault 2008

She argued that Wyeth should have warned health-care providers never to attempt IV-push injection because "other, safer methods" were available.

Legal Side Effects 2008

"As amputations continued to occur, Wyeth could have analyzed the accumulating data and added a stronger warning about IV-push administration of the drug," he wrote.

unknown title 2009

Though the drug's FDA-approved label did not prohibit this method, known as IV-push, it noted that "extreme care" was necessary to avoid hitting an artery because "likely" complications include "gangrene requiring amputation"

unknown title 2009

When she still felt nauseated, she was given an "IV-push" of the drug, with the second injection accidentally puncturing an artery.

unknown title 2009

When she still felt nauseated, she was given an "IV-push" of the drug, with the second injection accidentally puncturing an artery.

PE Angels Baseball 2009

"As we have discussed, the FDA did not consider and reject a stronger warning against IV-push injection of Phenergan," Stevens said.

The News Tribune - Tacoma - Homepage 2009

"As we have discussed, the FDA did not consider and reject a stronger warning against IV-push injection of Phenergan," Stevens said.

unknown title 2009

Wyeth attorney Bert Rein said the firm was unable to change the drug's warning label, which left to the physician the decision of whether to administer the drug by IV-push or by a slower method, such as IV drip.

unknown title 2009